|
|||
|
See also:
Email it to friends
|
Clip Preview:
1: J Pharmacol Exp Ther. 2007 Dec 18 [Epub ahead of print]
LNCaPCOX-2 cells expressed increased levels of survivin and Bcl-2 with enhanced activation of AKT Celecoxib treatment resulted in highly significant increases in the mRNA expression of the smooth muscle component desmin, the detoxification enzyme GSTpi and Nonsteroidal-Anti-inflammatory response gene NAG-1 in the LNCaPCOX-2 cell line when compared with LNCaPneo cells Our findings indicate both COX-2 dependent and independent mechanisms attributable to celecoxib and support its utility in the management of prostate cance |
||